Portfolio

Dyne Therapeutics

CEO John Cox

Dyne focuses on transforming the lives of people with serious muscle diseases by pioneering muscle-targeted therapies.

Dyne focuses on transforming the lives of people with serious muscle diseases by pioneering muscle-targeted therapies.

Dyne’s proprietary technologies provide the foundation for breakthrough treatments in myotonic dystrophy, Duchenne muscular disease and others. The company is based in Waltham, MA and assembled a world-class team of drug development experts.

Human Health

Dyne Therapeutics

US

1560 Trapelo Road,
Waltham, MA 02451

Industry

Biotech

Status

Current

Location

US